SCHEMBL1242429

SCHEMBL1242429

O=Cc1csc(C=Cc2ccccc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
CYP2A6 P11509 1/20 0.46
TRPA1 O75762 1/20 0.41
LMNA P02545 1/20 0.41
ALOX5 P09917 1/20 0.41
MAPK1 P28482 1/20 0.41
MAOB P27338 3/20 0.37
NFE2L2 Q16236 3/20 0.37
CYP19A1 P11511 2/20 0.37
MAOA P21397 2/20 0.37
RELA Q04206 1/20 0.37
KMT2A Q03164 2/20 0.37
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
HPGD P15428 1/20 0.36
PPARG P37231 1/20 0.36
HDAC3 O15379 1/20 0.35
TNKS O95271 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1242427 1.00 ALDH1A1 (0.46) ALDH1A1CYP2A6TRPA1LMNAALOX5
SCHEMBL20585391 0.88 MAOB (0.42) ALDH1A1ALOX5MAOBNFE2L2CYP19A1
SCHEMBL20585392 0.88 MAOB (0.42) ALDH1A1ALOX5MAOBNFE2L2CYP19A1
SCHEMBL27758588 0.87 ALDH1A1 (0.43) ALDH1A1CYP2A6TRPA1LMNAALOX5
SCHEMBL20586075 0.77 LMNA (0.42) ALDH1A1LMNAMAOBNFE2L2CYP19A1
SCHEMBL20586074 0.77 LMNA (0.42) ALDH1A1LMNAMAOBNFE2L2CYP19A1
SCHEMBL346857 0.75
SCHEMBL27597008 0.75 TTR (0.46) ALDH1A1LMNAMAPK1MAOBKMT2A
(Z)-1,2-Diphenylethene SCHEMBL29118819 0.75 ALDH1A1 (0.82) ALDH1A1CYP2A6TRPA1LMNAALOX5
SCHEMBL3400374 0.74 HCAR2 (0.46) ALDH1A1LMNAALOX5MAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7884124-B2 such as 2-Fluoro-4H-furo[3,2-b]pyrrole-5-carboxylate acid, used for the treatment of neuropathic pain, Alzheimer's disease, schizophrenia, ataxia and convulsions SEPRACOR INC. (US) 2011-02-08 US disclosed
CN-101511832-A Fused heterocyclic inhibitors of D-amino acid oxidase SEPRACOR INC (US) 2009-08-19 CN disclosed
EP-2057162-A2 FUSED HETEROCYCLIC INHIBITORS OF D-AMINO ACID OXIDASE Sepracor Inc. (US) 2009-05-13 EP disclosed
US-20080058395-A1 Fused heterocyclic inhibitors of D-amino acid oxidase SEPRACOR INC. (US) 2008-03-06 US disclosed
WO-2008005456-A2 FUSED HETEROCYCLIC INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2008-01-10 WO disclosed
US-20080004327-A1 FLUORO-SUBSTITUTED INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058395-A1 Fused heterocyclic inhibitors of D-amino acid oxidase DAO, DDO, AOX1 ALDH1A1 866/4885CYP2A6 937/4885TRPA1 3991/4885
US-20080004327-A1 FLUORO-SUBSTITUTED INHIBITORS OF D-AMINO ACID OXIDASE DAO, DDO, AOX1 ALDH1A1 622/4885CYP2A6 588/4885TRPA1 2330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.